Evidence Hub

Mixed infection with Burkholderia cepacia and Cutibacterium acnes following subarachnoid hemorrhage surgery: a case report

Yao L, Zhou C, Wu A, Fu Y, Wang H

Frontiers in medicine, 2026

Abstract

Intracranial mixed infection represents a rare and critical clinical scenario associated with high mortality and multi-organ failure, and its management remains extremely challenging. We report a 56-year-old female with chronic hepatitis B and intracranial hemorrhage, who developed a severe mixed infection with Burkholderia cepacia (Burkholderia cepacia) and Cutibacterium acnes (C. acnes). Notably, B. cepacia was isolated from blood and sputum specimens, whereas C. acnes was detected in cerebrospinal fluid. The patient experienced progressive systemic deterioration with high fever and multiple organ dysfunction. Multidisciplinary supportive care and targeted antimicrobial strategy achieved effective infection control and gradual recovery of hepatic and renal function. Nevertheless, irreversible neurological damage resulted in persistent coma, and the patient was discharged for palliative care 3 months later. This case highlights the therapeutic difficulties of severe mixed infections with intracranial involvement and provides clinical experience for the management of similar complex critical illnesses.

How strong is the evidence?

Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.

How the five levels of evidence work. The level is assigned automatically from the abstract and can be wrong, so check the paper.

Read the paper

Related studies

Go deeper in Evidence Hub

Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.

Open this study Sign up free